Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Nafamostat Efficacy in Phase 3 Registrational CRRT Study
Recruiting · NCT06150742 · Registry updated 2025-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nafamostat Efficacy in Phase 3 Registrational CRRT Study | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, acute kidney injury, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not applicable | 2025-10-15 | NCT06150742 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Talphera, Inc | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AdventHealth | Orlando | United States | 29 |
| Baylor University Medical Center | Dallas | United States | 87 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Henry Ford Health | Detroit | United States | 75 |
| Medical University of South Carolina | Charleston | United States | 628 |
| Mount Sinai | New York | United States | 58 |
| Northwell Health | Great Neck | United States | 17 |
| University of California Los Angeles | Los Angeles | United States | 87 |
| University of New Mexico | Albuquerque | United States | 51 |
| University of Pittsburgh Medical Center | Pittsburgh | United States | 127 |